Clinical Trial Update: A Study of the Pharmacokinetics and Immunologic Effects of Lipoic Acid in Multiple Sclerosis [Phase 1]

View source ↗

Summary

This Phase 1 study completed evaluating the pharmacokinetics and immunologic effects of alpha-lipoic acid in people with multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Alpha Lipoic Acid (alpha-lipoic acid)

Snippet

Sponsor: Oregon Health and Science University | Conditions: Multiple Sclerosis | Phase 1 | Status: COMPLETED